The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus ApproachMatthew Greenhawt, Javed Sheikh, Jonathan A. Bernstein et al.|The Journal of Allergy and Clinical Immunology In Practice|2021Cited by 210
Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year resultsDavid M. Fleischer, Hugh A. Sampson, Wayne G. Shreffler et al.|Journal of Allergy and Clinical Immunology|2020Cited by 101
Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: REALISE Randomized Clinical Trial ResultsJacqueline A. Pongracic, Philippe Bégin, Rémi Gagnon et al.|The Journal of Allergy and Clinical Immunology In Practice|2021Cited by 61
Varying Doses of Epicutaneous Immunotherapy With Viaskin Milk vs Placebo in Children With Cow’s Milk AllergyDaniel Petroni, Robert A. Wood, Philippe Bégin et al.|JAMA Pediatrics|2024Cited by 15
Sustained Effectiveness, Tolerability, and Safety of Long-Term Prophylaxis with Lanadelumab in Hereditary Angioedema: The Prospective, Phase 4, Noninterventional EMPOWER Real-World StudyJonathan A. Bernstein, Mark Weinstein, Stephen Betschel et al.|Advances in Therapy|2025Cited by 10